Peng‐Hsun Chase Chen
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)Quantitative BioSciences(US)
Publications by Year
Research Areas
Chemical Synthesis and Analysis, Click Chemistry and Applications, RNA and protein synthesis mechanisms, Monoclonal and Polyclonal Antibodies Research, Histone Deacetylase Inhibitors Research
Most-Cited Works
- → A Genetically Encoded, Phage‐Displayed Cyclic‐Peptide Library(2019)109 cited
- → An amber obligate active site-directed ligand evolution technique for phage display(2020)44 cited
- → A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease(2023)21 cited
- → Selective Targeting of Vibrios by Fluorescent Siderophore-Based Probes(2017)18 cited
- → Leveraging a Phage-Encoded Noncanonical Amino Acid: A Novel Pathway to Potent and Selective Epigenetic Reader Protein Inhibitors(2024)16 cited
- → An amber-encoding helper phage for more efficient phage display of noncanonical amino acids(2023)10 cited
- → Phage‐assisted , active site‐directed ligand evolution of a potent and selective histone deacetylase 8 inhibitor(2022)9 cited
- → Prioritization of Eleven-Nineteen-Leukemia Inhibitors as Orally Available Drug Candidates for Acute Myeloid Leukemia(2024)4 cited